Brian Holland

Q: What is Brian Holland's success rate?

Brian Holland currently has a success rate of 89.34195643505254.

Q: What is the average return of Brian Holland's calls?

Their stock ratings have generated an average return of 5.115280306982233.

DA Davidson | Consumer Defensive

Brian Holland is an analyst from DA Davidson specializing in the Consumer Defensive sector. Ranked #1737 out of 4639 analysts, they have issued 37 stock ratings with a success rate of 89.34% and an average return of 5.12%.

Brian Holland has a well-established track record, with 37 ratings issued in the Consumer Defensive sector. They have consistently delivered a success rate of 89.34% and an average return of 5.12%, underscoring their expertise and ability to identify winning opportunities for investors.

#1737

Out of 4639

Total Ratings

+89.34%

Success Rate

+5.12%

Average Return

Recent Ratings Analysis

HSY

Hold

May 04, 2026

Target

$208.00

Current

$182.01

Performance

0.00%

Brian Holland rated HSY as Neutral on May 04, 2026, setting a price target of 208. The Hold stance appears justified, as shares hovered around 182.01 with a 0.00% move.

VITL

Hold

May 04, 2026

Target

$16.00

Current

$13.00

Performance

0.00%

On May 04, 2026, VITL was given a Neutral rating by Brian Holland, with a target price of 16. Market indecision, reflected in sideways trading near 13, supported the cautious call.

MAMA

Buy

Apr 16, 2026

Target

$25.00

Current

$13.96

Performance

-4.32%

MAMA received a Buy rating from Brian Holland on Apr 16, 2026, aiming for 25. Price action was muted, as shares hovered around 13.96 despite the bullish outlook.

FRPT

Buy

Apr 13, 2026

Target

$101.00

Current

$63.56

Performance

-6.87%

On Apr 13, 2026, Brian Holland published a Buy outlook on FRPT, with a target of 101. Market action contradicted the Buy thesis, as shares slipped to 63.56.

SMPL

Hold

Apr 10, 2026

Target

$39.00

Current

$12.96

Performance

24.14%

Brian Holland on Apr 10, 2026 assigned SMPL a Neutral rating, with a price target of 39. Shares outperformed expectations, climbing 24.14% despite the neutral view.

MZTI

Hold

Mar 16, 2026

Target

$168.00

Current

$116.22

Performance

-20.62%

On Mar 16, 2026, Brian Holland reaffirmed MZTI with a Neutral rating, targeting 168. The Hold stance reflected market caution that was later justified.

CPB

Hold

Mar 12, 2026

Target

$30.00

Current

$20.50

Performance

-5.31%

CPB was rated Neutral by Brian Holland on Mar 12, 2026, with a price objective of 30. Investors who stayed cautious avoided some of the 5.31% decline.

NATR

Buy

Mar 12, 2026

Target

$33.00

Current

$26.03

Performance

3.29%

On Mar 12, 2026, Brian Holland initiated coverage on NATR with a Buy rating and target of 33. Neutral price movement of 3.29% leaves room for interpretation.

STKL

Buy

Feb 09, 2026

Target

$8.00

Current

$6.50

Performance

1.64%

Brian Holland issued a Buy recommendation for STKL on Feb 09, 2026, price target set at 8. The target of 8 remains in play, though confirmation will depend on future moves.

MDLZ

Hold

Feb 09, 2026

Target

$64.00

Current

$61.38

Performance

1.07%

On Feb 09, 2026, MDLZ was evaluated by Brian Holland, who gave a Neutral rating and target of 64. Hold sentiment was validated by subdued trading with no breakout beyond 61.38.

BRBR

Buy

Feb 05, 2026

Target

$34.00

Current

$17.36

Performance

-10.88%

Brian Holland rated BRBR as Buy on Feb 05, 2026, setting a price target of 34. The stock has underperformed, dropping 10.88% despite the bullish target of 34.

HAIN

Hold

Feb 03, 2026

Target

$1.50

Current

$0.63

Performance

-47.13%

On Feb 03, 2026, HAIN was given a Neutral rating by Brian Holland, with a target price of 1.5. The rating provided protection from downside risk as the stock fell to 0.6344.

OTLY

Buy

Nov 21, 2025

Target

$17.00

Current

$10.97

Performance

-5.51%

OTLY received a Buy rating from Brian Holland on Nov 21, 2025, aiming for 17. The rating hasn’t played out as hoped, with the stock trading 5.51% below expectations.

SJM

Hold

Aug 28, 2025

Target

$112.00

Current

$96.91

Performance

-9.19%

On Aug 28, 2025, Brian Holland published a Neutral outlook on SJM, with a target of 112. Weakness in the stock, now at 96.91, supported the conservative rating.

FLO

Hold

Aug 18, 2025

Target

$15.00

Current

$8.35

Performance

-47.05%

Brian Holland on Aug 18, 2025 assigned FLO a Neutral rating, with a price target of 15. The call successfully avoided chasing as shares lost 47.05%.

UTZ

Hold

Feb 24, 2025

Target

$16.00

Current

$7.69

Performance

-44.72%

On Feb 24, 2025, Brian Holland reaffirmed UTZ with a Neutral rating, targeting 16. The Hold stance reflected market caution that was later justified.

LANC

Hold

Feb 10, 2025

Target

$207.00

Current

$172.77

Performance

-7.40%

LANC was rated Neutral by Brian Holland on Feb 10, 2025, with a price objective of 207. Investors who stayed cautious avoided some of the 7.40% decline.

K

Buy

May 09, 2024

Target

$72.00

Current

$83.44

Performance

35.45%

On May 09, 2024, Brian Holland initiated coverage on K with a Buy rating and target of 72. The stock’s climb of 35.45% since the call highlights the foresight in the rating.

Frequency Asked Questions

Who is Brian Holland?

Brian Holland is an analyst from DA Davidson specializing in the Consumer Defensive sector.

What is Brian Holland's success rate?

Brian Holland currently has a success rate of +89.34%.

How many ratings has Brian Holland issued?

Brian Holland has issued 37 stock ratings so far.

What is the average return of Brian Holland's calls?

Their stock ratings have generated an average return of +5.12%.

What is Brian Holland's ranking?

Brian Holland is ranked #1737 out of 4639 analysts.

What types of ratings does Brian Holland give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Brian Holland?

You can follow Brian Holland by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Brian Holland?

Their latest rating was a Hold on HSY issued on 2026-05-04.